What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Timothy J. Kinsella mainly focuses on Radiation therapy, Surgery, Chemotherapy, Internal medicine and Randomized controlled trial.
The Radiation therapy study combines topics in areas such as Nuclear medicine and Urology.
His biological study deals with issues like Sarcoma, which deal with fields such as Gastroenterology.
The various areas that he examines in his Chemotherapy study include Regimen, Ovarian cancer, Amputation and Radiation sensitivity.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
His Randomized controlled trial research includes themes of Prospective cohort study and Intraoperative radiotherapy.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (1951 citations)
- Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy (939 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Radiation therapy, Surgery, Internal medicine, Cancer research and Radiology.
His studies deal with areas such as Cancer, Nuclear medicine and Pathology as well as Radiation therapy.
His Nuclear medicine research integrates issues from Radiosurgery and Toxicity.
His research investigates the connection with Surgery and areas like Sarcoma which intersect with concerns in Total body irradiation.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His study on Cancer research also encompasses disciplines like
- Cell cycle which connect with Cell culture,
- DNA repair, which have a strong connection to Molecular biology,
- DNA damage that connect with fields like Cell biology.
He most often published in these fields:
- Radiation therapy (35.60%)
- Surgery (25.17%)
- Internal medicine (17.23%)
What were the highlights of his more recent work (between 2005-2020)?
- Radiation therapy (35.60%)
- Cancer research (15.42%)
- Internal medicine (17.23%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Radiation therapy, Cancer research, Internal medicine, Surgery and Oncology.
His biological study spans a wide range of topics, including Cancer, Pancreatic cancer, Therapeutic index and Prodrug, Pharmacology.
His Cancer research research incorporates elements of Autophagy, Apoptosis, DNA damage and DNA repair, DNA mismatch repair.
In his work, Cell culture is strongly intertwined with Molecular biology, which is a subfield of DNA damage.
His Internal medicine study incorporates themes from Gastroenterology and Pathology.
His work deals with themes such as Neoadjuvant therapy and Brain metastasis, which intersect with Surgery.
Between 2005 and 2020, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (1951 citations)
- A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma (200 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Timothy J. Kinsella mostly deals with Cancer research, Molecular biology, Surgery, Internal medicine and Cancer.
His research integrates issues of Genetics, Programmed cell death and DNA repair in his study of Cancer research.
Timothy J. Kinsella combines subjects such as Cell culture and DNA damage with his study of Molecular biology.
His study in Surgery focuses on Radiation therapy, Chemotherapy and Proportional hazards model.
Timothy J. Kinsella studies Chemoradiotherapy, a branch of Radiation therapy.
His Internal medicine research focuses on Oncology and how it relates to Toxicity, Breast cancer, Concomitant and Paclitaxel.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
